ONCOFAP is a high-affinity ligand designed to target fibroblast activation protein (FAP), a serine protease that is frequently overexpressed in the tumor microenvironment of various epithelial cancers.… Read more
ONCOFAP is a high-affinity ligand designed to target fibroblast activation protein (FAP), a serine protease that is frequently overexpressed in the tumor microenvironment of various epithelial cancers. Due to its ability to selectively bind FAP-positive stromal cells, this compound is primarily utilized in cancer research for the development of targeted imaging agents, theranostic probes, and drug delivery systems. Laboratories working with this molecule rely on a comprehensive range of related compounds, including synthetic impurities, metabolic degradation products, and stable isotope labelled standards, to facilitate rigorous scientific analysis. These analytical tools are essential for impurity profiling, method validation, and maintaining strict quality control during the development of FAP-targeted therapies. By employing these reference standards, researchers can ensure the precision and reliability of quantitative measurements in preclinical studies and the ongoing evaluation of oncology diagnostics.